Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial

Scandinavian Journal of Gastroenterology

Volumn 31, Issue 8, 1996, Pages 778-785

  Lorenz Meyer, H ^a   Bauer, P ^b   Nicolay, C ^b   Schulz, B ^b   Purrmann, J ^b   Fleig, W E ^b   Scheurlen, C ^b   Koop, I ^b   Pudel, V ^b   Carr, L ^b  

^a KLINIKUM BRAUNSCHWEIG   (Germany)

^b NONE

Author keywords

Crohn's disease; Low carbohydrate diet; Maintenance of remission; Omega 3 fatty acids; Randomized controlled multicenter trial

Indexed keywords

C REACTIVE PROTEIN; CARBOHYDRATE; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; METHYLPREDNISOLONE; OMEGA 3 FATTY ACID;

ADULT; ARTICLE; CARBOHYDRATE DIET; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DIARRHEA; DOUBLE BLIND PROCEDURE; FAT INTAKE; FEMALE; FISTULA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NERVOUSNESS; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION; SKIN MANIFESTATION;

EID: 9344225756     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529609010352     Document Type: Article

References (27)

1. Stenson EF. Role of eicosapentanoids as mediators of inflammation in inflammatory bowel disease. Scand J Gastroenterol 1990;25 Suppl 172:13-8.
2. Sharon P, Stenson WF. Enhanced sythesis of leucotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 1984;86:453-60.
3. Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J. In vivo profiles of eicosanoids in ulcerative colitis, Crohn's colitis and Clostridium difficile-colitis. Gastroenterology 1988;95:11-7.
4. Lee TK, Hoover RI, Williams PD, Sperling RI, Ravalese J, Spur BW, et al. Effect of dietary enrichment with eicosapentanoic and docusahexanoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 1985;312:1217-24.
5. Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JWM, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor nekrosis factor by mononuclear cells. N Engl J Med 1989:320:265-71.
6. Wallace JL, Keenan CM, Finn NJ. Antiinflammatory effects of a fish oil diet in a rat model of chronic colitis. Gastroenterology 1989;96:A83.
7. Empey LR, Garg ML, Fedorac RN. Eicosapentanoic acid (fish oil)-enriched diet is protective in rat experimental colitis. Gastroenterology 1989;96:A83.
8. O'Morain CA. Nutritional therapy in ambulatory patients. Dig Dis Sci 1987;32:95S-9s.
9. Lorenz R, Weber PC, Szimnau P, Heldwein W, Strasser T, Loeschke K, et al. Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease - a randomized, placebo-controlled, double-blind crossover trial. J Int Med 1989:225 Suppl 1:225-32.
10. Salomon P, Kornblut AA, Janowitz HD. Treatment of ulcerative colitis with fish-oil omega-3 fatty acids: an open trial. J Clin Gastroenterol 1990;12:157-61.
11. Greenfield SM, Green AT, Teare JP, Jenkins AP, Punchard NA, Ainley CC, et al. A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis. Aliment Pharmacol Ther 1993;7:159-66.
12. Katschinsky B, Logan RFA, Edmond M, Langman MJS. Smoking and sugar intake are separate but interactive risk factors in Crohn's disease. Gut 1988;29:1202-6.
13. Brandes W, Lorenz-Meyer H. Zuckerfreie Diät: Eine neue Perspektive zur Behandlung des Morbus Crohn? Eine randomisierte Studie. Z Gastroenterol 1981;19:1-12.
14. Heaton KW, Thornton JR, Emmet PM. Treatment of Crohn's disease with unrefined carbohydrate, fibre-rich diet. Br Med J 1979;2:764-6.
15. Alun-Jones V, Dickinson RJ, Woramn E, Wilson AJ, Freeman AH, Hunter JO. Crohn's disease: maintainance of remission by diet. Lancet 1985;2:177-80.
16. Ritchie J, Wadsworth J, Lennard-Jones JE, Rogers E. Controlled multicenter therapeutic trial of an unrefined carbohydrate, fibrerich diet in Crohn's disease. Br Med J 1987;295:517-20.
17. Stange EF, Schmid U, Fleig WE, Ditschuneit H. Ausschlußdiät bei Morbus Crohn. Eine kontrollierte, randomisierte Studie. Z Gastreoenterol 1990;28:561-4.
18. Malchow H, Daiss W. Diagnostik des Morbus Crohn. Dtsch Med Sochenschr 1984;109:1770-5.
19. Scheurlen M, Clemens MR, Gaede P, Daiss W, Reichert U, Jaschonek K. In: Wechsler G, Swobodnik W, editors. Eikosapentaen- und Docosahexaensäure: Zell- und Serumanalysen in Omega-3 Fettsäuren. Weinheim: Edition Medizin VCH, 1-10.
20. BMDP statistical software. Berkeley [CA]: University of California Press, 1988.
21. Best WR, Becktel JM, Singleton JW. Development of a Crohn's disease activity index. Gastroenterology 1976;70:439-44.
22. Lutz W. Morbus Crohn unter kohlehydratarmer Kost. MMW 1987;50:921-3.
23. Pudel V. Das Check-List-Protokoll als einfache Methode zur Erfassung der Ernährungsgewohnheiten Adipöser. Int Z Vitam Ernaehrungsforsch 1974;44:246.
24. Phillipson BE, Rothrock DW, Connor WE, Harris WS, Illingworth DR. Reduction of plasma lipids, lipoproteins and apoproteins by dietary fish oils in patients with hypertriglycerinemia. N Engl J Med 1985;312:1210-6.
25. Malchow H, Ewe K, Brandes JW. European cooperative Crohn's disease study (ECCDS): results of drug treatment. Gastroenterology 1984;86:249-66.
26. Summers RW, SWitz DM, Sessions JT Jr, Becktel JM, Best WR, Kern F Jr, et al. National Coopertive Crohn's Disease Study: results of drug treatment. Gastroenterology 1979;77: 847-69.
27. Esteve-Comas M, Raimirez M, Fernandez-Banarez F, Abad-Lacruz A, Gil A, Cabre E, et al. Plasma polyunsaturated fatty acid pattern in active inflammatory bowel disease. Gut 1992;33: 1365-9. This trial was conducted under the scientific direction of H. Lorenz-Meyer, with the participation of the following members: Städt. Krankenhaus Friedrichshafen, H. Lorenz-Meyer; Universitäts-Klinik Düsseldorf, J. Purrmann; Universitäts-Klinik München-Großhadern, C. Scheurlen; Universitäts-Klinik Tübingen, M. Scheurlen and W. Daiss; Universitäts-Klinik Erlangen, W. E. Fleig and M. Decker; Universitäts-Klinik Würzburg, R. Jöres; Städt. Krankenhaus Esslingen, R. Hoffmann; Städt. Krankenhaus Mutlangen, K. Weigand; Universitäts-Klinik Frankfurt, V. Lehnen-Holtum; Universitäts-Klinik Köln, W. Kruis; Städt. Krankenhaus Heilbronn, U. Römmele; Medizinische Klinik II Rotenburg/ Wümme, E. Schröter and H. Schomerus; Universitäts-Klinik Giessen, T. Linn; Klinikum Rechts der Isar München, X. Kestler; Vitalisklinik Bad Hersfeld, K. Warm; Universitäts-Klinik Bonn, C. Schmidt; Städt. Krankenhaus Bielefed, U. Junge; Medizinische Klinik Dortmund, L. Huk; Kreiskrankenhaus Heidenheim, H. Sommer; Julius-Spital Würzburg, I. O. Auer; Klinikum Mannheim, R Gladisch; Fachklinik Fränkische Saale Bad Neustadt, S. Gutschmidt; Institut für Ernährung der Universität Göttingen, V. Pudel (patient diaries); Institut für Medizinische Statistik der Universität, Wien, P. Bauer; Refrath bei Köln, C. Nicolay (statistics);